Patent details

EP2004225 Title: REGIMENS FOR IMMUNISATION WITH MENINGOCOCCAL CONJUGATES.

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP2004225
WO Application Number:
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP07753720.7
WO Publication Number:
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Switzerland (CH)
Publications:

Dates

Filing date:
22/03/2007
Grant date:
25/04/2012
EP Publication Date:
25/04/2012
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
25/04/2012
EP B1 Publication Date:
25/04/2012
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
11/06/2012
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
21/03/2027
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
22/12/2021
 
 

 

Name:
GlaxoSmithKline Biologicals S.A.
Address:
Rue de l'Institut 89, 1330, Rixensart, Belgium (BE)

Historical Applicant/holder

From:
25/04/2012
To:
22/12/2021

 

Name:
Novartis AG
Address:
Corporate Intellectual Property Lichtstrasse 35, 4056 BASEL, Switzerland (CH)

Agent

Name:
ir. F.A. Geurts c.s.
From:
15/12/2017
Address:
Octrooibureau Vriesendorp & Gaade B.V. Koninginnegracht 19, 2514 AB, Den Haag, Netherlands (NL)
To:

Inventor

Name:
DANZIG, Lisa
Address:
EMERYVILLE, CA 94662-8097, United States of America (US)

Priority

Priority Patent Number:
785234 P
Priority Date:
22/03/2006
Priority Country:
United States of America (US)

Classification

Main IPC Class:
A61K 39/095;
IPC or IDT classification:
A61P 31/04;

Publication

Bulletin

1

Bulletin Heading:
CO
Journal edition number:
05/22
Publication date:
02/02/2022
Description:
Changes in the Netherlands Patent Register

2

Bulletin Heading:
VB2
Journal edition number:
16/16
Publication date:
20/04/2016
Description:
Requests for restoration and notices of objection, notices of objection to Court, notices of objection to appelate court ex NL Patent Law 1995 in respect of which a decision has been taken. Opposition(s) decisions ex European Patent Convention

3

Bulletin Heading:
VB1
Journal edition number:
2015/19
Publication date:
06/05/2015
Description:
Requests for restoration and notices of objection, notices of objection to Court, notices of objection to appelate court ex NL Patent Law 1995. Opposition(s) filed ex European Patent Convention

4

Bulletin Heading:
VB1
Journal edition number:
2013/11
Publication date:
13/03/2013
Description:
Requests for restoration and notices of objection, notices of objection to Court, notices of objection to appelate court ex NL Patent Law 1995. Opposition(s) filed ex European Patent Convention

5

Bulletin Heading:
EP3
Journal edition number:
2012/26
Publication date:
27/06/2012
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

6

Bulletin Heading:
EP2
Journal edition number:
2012/18
Publication date:
02/05/2012
Description:
European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:
201616
Publication date:
20/04/2016
Description:
Opposition rejected; Patent maintained as granted

2

Issue number:
201518
Publication date:
29/04/2015
Description:
Opposition procedure started

3

Issue number:
201518
Publication date:
29/04/2015
Description:
Opposition Withdrawn

4

Issue number:
201310
Publication date:
06/03/2013
Description:
Opposition procedure started

5

Issue number:
201217
Publication date:
25/04/2012
Description:
Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
RC202102715A
Date Registered:
22/12/2021
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. F.A. Geurts c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
GlaxoSmithKline Biologicals S.A.
Address:
Rue de l'Institut 89, 1330, Rixensart, Belgium (BE)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
31/03/2026
Annual Fee Number:
20
Annual Fee Amount:
1400 Euro
Last Annual Payment Date:
19/02/2025
Last Annual Fee Paid Number:
19
Last Annual Fee Paid Amount:
1300 Euro
Payer:
Anaqua Services
Filing date Document type Document Description Number of pages File Type
15/12/2017 Incoming Correspondence Paper Correspondence address details 1 PDF /0/2/7/3/5/0507753720/docs/ep07753720.7_2_incomingcorrespondencepaper20171215115909456.pdf
11/06/2012 Description Translated description 25 PDF /0/2/7/3/5/0507753720/docs/ep07753720.7_0_description20120611.pdf
11/06/2012 Outgoing Correspondence Outgoing Letter 1 PDF /0/2/7/3/5/0507753720/docs/ep07753720.7_1_outgoingcorrespondence20120611.pdf
11/06/2012 Claims Translated claims 3 PDF /0/2/7/3/5/0507753720/docs/ep07753720.7_3_claims20120611.pdf
11/06/2012 Incoming Correspondence Paper Accompanying letter incoming document 2 PDF /0/2/7/3/5/0507753720/docs/ep07753720.7_4_incomingcorrespondencepaper20120611.pdf